Radient Pharmaceuticals Corporation fka RXPC

[Gold Seeker]

The trademark application was rejected because the trademark name is just a description of the test and not a specific identifiable name.

Also, the sample of the specimen submitted was clearly not something used in commerce prior to the application date. It clearly had "rough draft" printed on the specimen and that would not have been used in commerce. The USPT board has asked for proof that the specimen has been used in actual commerce prior to the date of the application.

Gartner has 6 months to reply from the date of application.